Entyvio Alternatives Compared
Entyvio | Zeposia | Upadacitinib |
|
---|
Entyvio (vedolizumab) | Zeposia (ozanimod) | Upadacitinib |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Entyvio infusion is an integrin receptor antagonist that may be used to reduce inflammation associated with moderate to severe ulcerative colitis or Crohn's disease. It targets the gut specifically... View more |
Prescription only
Zeposia is an S1P receptor modulator that may be used to treat relapsing forms of multiple sclerosis or ulcerative colitis in adults. It requires a 7-day titration period and reduces lymphocyte... View more |
Prescription only
Prescribed for Crohn's Disease, Ankylosing Spondylitis, Atopic Dermatitis, Non-Radiographic Axial Spondyloarthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Rheumatoid... View more |
Related suggestions Ulcerative Colitis
|
|||||||
More about Entyvio (vedolizumab) | More about Zeposia (ozanimod) | More about Upadacitinib | ||||||||
Ratings & Reviews | ||||||||||
Entyvio has an average rating of 6.1 out of 10 from a total of 153 ratings on Drugs.com. 47% of reviewers reported a positive effect, while 29% reported a negative effect. |
Zeposia has an average rating of 8.0 out of 10 from a total of 6 ratings on Drugs.com. 80% of reviewers reported a positive effect, while 0% reported a negative effect. |
Upadacitinib has an average rating of 6.7 out of 10 from a total of 175 ratings on Drugs.com. 53% of reviewers reported a positive effect, while 24% reported a negative effect. |
||||||||
Drug Class | ||||||||||
Side Effects | ||||||||||
See also: Entyvio side effects in more detail. |
See also: Zeposia side effects in more detail. |
See also: upadacitinib side effects in more detail. |
||||||||
Generic Availability | ||||||||||
N/A |
N/A |
|||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
View all Entyvio prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Form(s) Available | ||||||||||
|
|
N/A |
||||||||
Brand Names | ||||||||||
Other vedolizumab brands include: Entyvio Pen |
N/A |
Rinvoq, Rinvoq LQ | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
600 hours |
264 hours |
14 hours |
||||||||
CSA Schedule ** View glossary of terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 152 drugs are known to interact with Entyvio:
|
A total of 893 drugs are known to interact with Zeposia:
|
A total of 550 drugs are known to interact with upadacitinib:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
May 20, 2014 |
March 25, 2020 |
August 16, 2019 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient resources | ||||||||||
Professional Resources | ||||||||||
Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.